Lipopolysaccharide-induced biphasic inositol 1,4,5-trisphosphate response and tyrosine phosphorylation of 140-kilodalton protein in mouse peritoneal macrophages

J Immunol. 1997 Feb 1;158(3):1370-6.

Abstract

We previously showed that a relatively high dose of LPS induced the selective translocation of protein kinase C-beta (PKC-beta) in LPS-responsive mouse macrophages. This result suggested that phosphatidylinositol-specific phospholipase C (PLC) might be activated in the upstream of PKC-beta. Stimulation of C3H/HeN mouse macrophages by LPS induced the characteristic phosphatidylinositol-1,4,5-trisphosphate (IP3) response, that is, a biphasic response consisting of a rapid increase occurring within the first 1 min, and another increase beginning at around 1 min after stimulation. Only the first response was disappeared when cells were treated with a platelet-activating factor receptor antagonist. LPS-inducible TNF-alpha gene activation, however, was not suppressed by the same antagonist, but suppressed by PKC inhibitors. LPS-stimulated macrophage lysates showed tyrosine phosphorylation of some proteins, and the strongest phosphorylation was observed at molecular mass of 140 kDa. The phosphorylation of this protein started at 40 s after LPS stimulation and continued to increase. Anti-PLC-gamma2 Ab seemed to recognize the same protein as the tyrosine-phosphorylated 140-kDa protein. A low dose of LPS (1 ng/ml) could not induce the tyrosine phosphorylation of this protein. Furthermore, LPS induced only the first phase change, but not the second phase increase in LPS-hyporesponsive C3H/HeJ mouse macrophages. These results indicate that the first phase rapid IP3 change, which is also seen in HeJ macrophages, is mediated via a platelet-activating factor receptor, and is not responsible for TNF-alpha production, while the second phase change mediated by a molecule other than CD14 is responsible for PKC-beta translocation and TNF-alpha production. The results also suggest that the later IP3 change is considered to be mediated through a gamma2 type of phosphatidylinositol-specific PLC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzoquinones
  • Dose-Response Relationship, Drug
  • Inositol 1,4,5-Trisphosphate / metabolism*
  • Isoenzymes / metabolism
  • Lactams, Macrocyclic
  • Lipopolysaccharides / pharmacology*
  • Macrophages, Peritoneal / metabolism*
  • Male
  • Mice
  • Mice, Inbred C3H
  • Molecular Weight
  • Phospholipase C gamma
  • Phosphoproteins / metabolism*
  • Phosphotyrosine / metabolism*
  • Platelet Membrane Glycoproteins / antagonists & inhibitors
  • Platelet Membrane Glycoproteins / physiology
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Quinones / pharmacology
  • Receptors, Cell Surface*
  • Receptors, G-Protein-Coupled*
  • Rifabutin / analogs & derivatives
  • Signal Transduction
  • Type C Phospholipases / metabolism

Substances

  • Benzoquinones
  • Isoenzymes
  • Lactams, Macrocyclic
  • Lipopolysaccharides
  • Phosphoproteins
  • Platelet Membrane Glycoproteins
  • Quinones
  • Receptors, Cell Surface
  • Receptors, G-Protein-Coupled
  • platelet activating factor receptor
  • Rifabutin
  • Phosphotyrosine
  • herbimycin
  • Inositol 1,4,5-Trisphosphate
  • Protein-Tyrosine Kinases
  • Type C Phospholipases
  • Phospholipase C gamma